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Over the last decade or so the Radiology Diagnostic
Oncology Group (RDOG) have published results of a
number of important studies comparing US, CT and MR
imaging for cancer diagnosis and staging applications.
Each is well planned, accrues hundreds of patients and
involves imaging in a number of major USA cancer
centers. The studies have some limitations but are always
important, credible and influential.
Over the last three years the RDOG has published
results of a major study of women with suspected primary
ovarian cancer. These concern:
1. Comparison of US, CT and MR imaging for
diagnosis and staging prior to surgery [1].
2. Evaluation of these modalities in predicting surgi-
cal findings [2].
3. Comparison of primary and metastatic ovarian
cancers [3].
These studies have shown that both CT and MR
imaging are superior to US in assessment of the
nature of ovarian masses, with the highest accuracy for
MR imaging [1]. In assessment of the stage of disease
all had similar accuracy (0.91) since the presence of
ascites predicted peritoneal dissemination. However in
determination of the sites and extent of metastatic
deposits, US was inferior to both CT and MR imaging [2].
US was poor for depiction of peritoneal metastases.
The ready availability of CT makes it the investigation
of choice for planning surgery with suspected ovarian
cancer. It should replace urography and barium studies
for assessment of hollow organ involvement.
CT remains inferior to surgical staging in detection
of tiny peritoneal, omental and mesenteric nodules
even with meticulous technique in the hands of world
experts [3]. But this is not its role. Rather, in the presence
of bulky disease CT predicts the likely success of cyto-
reductive surgery. CT also indicates when the gynaecolo-
gist may require assistance from other surgical colleagues
to achieve effective debulking, when, for example,
there is involvement of ureters, pelvic small bowel or
colon. Bulky disease in the supracolic compartment
around the spleen and stomach, within suprarenal lymph
nodes, and affecting the subdiaphragmatic recesses and
parenchyma of the liver is usually beyond the scope of
surgery.
Another advantage of CT is the use of guided biopsy
as an alternative to surgery to provide a definitive
histological diagnosis in women with inoperable disease
and in women with poor performance status [4]. There is
current interest in neoadjuvant chemotherapy followed by
interval surgery for these women. Biopsy is also valuable
when there is a concern that peritoneal carcinomatosis is
a result of disease metastatic to the ovary from the breast
or GI tract. The CT appearance of ovarian metastases
may be indistinguishable from that of primary ovarian
cancer. Both may produce the bilateral, solid masses
considered typical of Krukenberg tumours. In further
analysis of the RDOG study the only factor favouring
primary ovarian cancer was multilocularity as shown by
US or MR imaging [5]. This was not a significant feature
for CT. The stomach, colon, appendix and pancreas are
within the examination volume and should be inspected
as potential primary cancer sites within the abdomen. A
definitive histologic diagnosis is required as debulking
surgery is inappropriate for such metastatic disease and
chemotherapeutic regimen differ.
The RDOG studies and other recent work argue
for a central role of CT in multidisciplinary care
and planning management of ovarian cancer and
peritoneal carcinomatosis. Peritoneal biopsy, using CT
or US guidance, is valuable and useful alternative
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to laparoscopy or exploratory surgery when there is
diagnostic uncertainty, or with advanced disease beyond
the scope of cytoreductive surgery [4].
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